Biopharmaceutical aspects of an assessment of quality of ointments with nimesulid at determination of stability in the course of storage
Abstract
The article reflects the biopharmaceutical aspects of assessing the quality of the ointment with nimesulide and alantoin in determining the stability during storage.
References
2. Balabanova R. M. Nimesulide - anti-inflammatory drug with selective inhibition of COX-2 // Russian Med. journ - 2001. No. 2. - pp. 14-17.
3. Barskova V.G. Nimesulide in the treatment of gouty arthritis // Consilium medicum. 2008 N 2. P. 19-23.
4. Kovalenko VM, Shuba N. M., Bortkevich O. P., Bilyavskaya Yu. V. Basic approaches to the management of patients with rheumatoid arthritis according to the latest recommendations of the European anti-rheumatic league (2010) // Ukr. rheumatologist journal - 2010. - № 4 (42). - P. 6-17.
5. Brinker A., Beitz J. Use of a spontaneous adverse drug database for identification of unanticipated drug benefits // Clin. Pharmacol. Ther - 2002. - 102 p.
6. Husher D., Merkesdal S., Thiele K. et al. Cost of disease in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany // Ann. Rheum Dis 2006 V. 65. P. 1175- 1183.

This work is licensed under a Creative Commons Attribution 4.0 International License.